Gašperšič Jernej, Kastelic Miha, Novak Uroš, Likozar Blaž
Acta Chim Slov. 2018;65(4):769-789.
Chinese hamster ovary (CHO) epithelial cells are one of the most used therapeutic medical lines for the production of different biopharmaceutical drugs. They have a high consumption rate with a fast duplication cycle that makes them an ideal biological clone. The higher accumulated amounts of toxic intracellular intermediates may lead to lower organism viability, protein productivity and manufactured biosimilar, so a careful optimal balance of medium, bioreactor operational parameters and bioprocess is needed. A precise phenomenological knowledge of metabolism's chemical transformations can predict problems that may arise during batch, semi-continuous fed batch and continuous reactor operation. For a better detailed understanding (and relations), future performance optimization and scaling, mechanistic model systems have been built. In this specific work, the main metabolic pathways in mammalian structured CHO cultures are reviewed. It starts with organic biochemical background, controlling associated phenomena and kinetics, which govern the sustaining conversion routes of biology. Then, individual turnover paths are described, overviewing standard mathematical formulations that are commonly applied in engineering. These are the core of black box modeling, which relates the substrates/products in a simplified relationship manner. Moreover, metabolic flux analysis (MFA)/flux balance analysis (FBA), that are traditionally characterizing mechanisms, are presented to a larger portion extent. Finally, similarities are discussed, illustrating the approaches for their structural design. Stated variables' equations, employed for the description of the growth in the controllable environmental conditions of a vessel, the researched reaction series of proliferating dividing CHO population, joint with the values of maximal enzymatic activity, and solutions are outlined. Processes are listed in a way so that a reader can integrate the state-of-the-art. Our particular contribution is also denoted.
中国仓鼠卵巢(CHO)上皮细胞是用于生产不同生物制药药物的最常用治疗性细胞系之一。它们消耗率高,复制周期快,使其成为理想的生物克隆体。细胞内有毒中间体积累量增加可能导致细胞活力、蛋白质生产率降低以及生物仿制药产量下降,因此需要仔细优化培养基、生物反应器操作参数和生物工艺之间的平衡。对代谢化学转化的精确现象学认识可以预测分批、半连续补料分批和连续反应器操作过程中可能出现的问题。为了更详细地理解(及其关系)、优化未来性能和扩大规模,已经建立了机理模型系统。在这项具体工作中,对哺乳动物结构化CHO培养中的主要代谢途径进行了综述。首先介绍有机生化背景、控制相关现象和动力学,这些决定了生物的持续转化途径。然后描述各个周转途径,概述工程中常用的标准数学公式。这些是黑箱建模的核心,它以简化的关系方式关联底物/产物。此外,还较大篇幅地介绍了传统上用于表征机理的代谢通量分析(MFA)/通量平衡分析(FBA)。最后讨论了相似之处,说明了其结构设计方法。列出了用于描述容器可控环境条件下生长的状态变量方程、所研究的增殖分裂CHO群体的反应系列,以及最大酶活性值和解决方案。过程的列出方式使读者能够整合最新技术。我们的具体贡献也予以了说明。